You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 42 No. 2, February 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Dexamethasone Suppression Test and Pituitary-Adrenocortical Function

Walter Armin Brown, MD; Gabor Keitner, MD; C. Brandon Qualls, MD; Richard Haier, PhD

Arch Gen Psychiatry. 1985;42(2):121-123.


Abstract

• The dexamethasone suppression test (DST) as now commonly carried out in psychiatric settings yields "abnormal" results in many conditions including the healthy state. To determine whether the DST accurately identifies patients with physiologically meaningful increases in pituitary-adrenocortical activity, we compared DST results to baseline urinary cortisol level. Thirty-four psychiatric inpatients underwent a 24-hour urine collection and then a DST using 1 or 2 mg of dexamethasone. With the common 1-mg DST, 24-hour urinary cortisol levels in nonsuppressors and suppressors did not differ. With the 2-mg DST, however, nonsuppressors had significantly higher urinary cortisol levels than suppressors, and all nonsuppressors had urinary cortisol levels above the normal range. Thus, the 1-mg DST may not identify the heuristically important subgroup of psychiatric patients who have a pathophysiologically meaningful alteration in pituitary-adrenal regulation.



Author Affiliations

From the Veterans Administration Medical Center (Dr Brown), Department of Psychiatry, Brown University (Drs Brown, Keitner, and Qualls), and Butler Hospital (Drs Keitner and Qualls), Providence, RI; and the Department of Psychiatry, University of California at Irvine (Dr Haier).


Footnotes

Accepted for publication Sept 10, 1984.

Reprint requests to VA Medical Center, Davis Park, Providence, RI 02908 (Dr Brown).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cortisol Secretion in Prepubertal Children With Major Depressive Disorder: Episode and Recovery
Puig-Antich et al.
Arch Gen Psychiatry 1989;46:801-809.
ABSTRACT  

Dexamethasone Suppression Test and Plasma Dexamethasone Levels in Bulimia
Walsh et al.
Arch Gen Psychiatry 1987;44:797-800.
ABSTRACT  

Neuroendocrine Aspects of Primary Endogenous Depression: I. Cortisol Secretory Dynamics in Patients and Matched Controls
Rubin et al.
Arch Gen Psychiatry 1987;44:328-336.
ABSTRACT  

The Dexamethasone Suppression Test in Stroke
Fogel
Arch Neurol 1986;43:105-105.
ABSTRACT  

Cortisol Secretion in Endogenous Depression: I. Basal Plasma Levels
Halbreich et al.
Arch Gen Psychiatry 1985;42:904-908.
ABSTRACT  

Cortisol Secretion in Endogenous Depression: II. Time-Related Functions
Halbreich et al.
Arch Gen Psychiatry 1985;42:909-914.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.